Does eplerenone have a future in the management of hypertension in Europe?

被引：4

作者：

Gosse, P.

Macfadyen, R. J.

机构：

[1] Bordeaux Univ, CHU Bordeaux, Hop St Andre, Hypertens Unit, F-33075 Bordeaux, France

[2] City Hosp, Univ Dept Med, Birmingham, W Midlands, England

来源：

JOURNAL OF HUMAN HYPERTENSION | 2006年 / 20卷 / 11期

关键词：

D O I：

10.1038/sj.jhh.1002070

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：829 / 832

页数：4

共 18 条

[1] Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension [J].

Burgess, ED ;

Lacoucière, Y ;

Ruilope-Urioste, LM ;

Oparil, S ;

Kleiman, JH ;

Krause, S ;

Roniker, B ;

Maurath, C .

CLINICAL THERAPEUTICS, 2003, 25 (09) :2388-2404

[2] ANTIANDROGENIC EFFECT OF SPIROLACTONES - MECHANISM OF ACTION [J].

CORVOL, P ;

MICHAUD, A ;

MENARD, J ;

FREIFELD, M ;

MAHOUDEAU, J .

ENDOCRINOLOGY, 1975, 97 (01) :52-58

[3] Efficacy and tolerability of eplerenone and losartan in hypertensive of eplerenone and black and white patients [J].

Flack, JM ;

Oparil, S ;

Pratt, JH ;

Roniker, B ;

Garthwaite, S ;

Kleiman, JH ;

Yang, YH ;

Krause, SL ;

Workman, D ;

Saunders, E .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (07) :1148-1155

[4]

FROMENT A, 1971, EXTERNAL ACTIVITY AL, P64

[5] Prevention of cardiovascular disease in clinical practice: The Joint British Societies' (JBS 2) guidelines [J].

Jessani, S. ;

Watson, T. ;

Cappuccio, F. P. ;

Lip, G. Y. H. .

JOURNAL OF HUMAN HYPERTENSION, 2006, 20 (09) :641-645

[6] EFFICACY AND TOLERANCE OF SPIRONOLACTONE IN ESSENTIAL-HYPERTENSION [J].

JEUNEMAITRE, X ;

CHATELLIER, G ;

KREFTJAIS, C ;

CHARRU, A ;

DEVRIES, C ;

PLOUIN, PF ;

CORVOL, P ;

MENARD, J .

AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (10) :820-825

[7] A review of the medical treatment of primary aldosteronism [J].

Lim, PO ;

Young, WF ;

MacDonald, TM .

JOURNAL OF HYPERTENSION, 2001, 19 (03) :353-361

[8] The 45-year story of the development of an anti-aldosterone more specific than spironolactone [J].

Ménard, JL .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 217 (1-2) :45-52

[9] Efficacy of low-dose spironolactone in subjects with resistant hypertension [J].

Nishizaka, MK ;

Zaman, MA ;

Calhoun, DA .

AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (11) :925-930

[10] Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [J].

Pitt, B ;

Remme, W ;

Zannad, F ;

Neaton, J ;

Martinez, F ;

Roniker, B ;

Bittman, R ;

Hurley, S ;

Kleiman, J ;

Gatlin, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1309-1321

← 1 2 →